Ibrutinib-related atrial fibrillation: Therapeutic challenges
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218785983
Abstract: Ibrutinib is a drug used in several lymphohyperplastic diseases. Its use is associated with an increased risk of atrial fibrillation. New-onset atrial fibrillation in this setting is a true challenge as several antiarrhythmic drugs are… read more here.
Keywords: atrial fibrillation; fibrillation; fibrillation therapeutic; related atrial ... See more keywords